Clinical Trials Logo

Root Canal Obturation clinical trials

View clinical trials related to Root Canal Obturation.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04935736 Completed - Clinical trials for Root Canal Obturation

Postoperative Pain After Root Canal Obturation With Sealer Containing Prednisolone.

Start date: June 30, 2021
Phase: N/A
Study type: Interventional

The study design is a multicentric randomized controlled clinical trial. 238 subjects (teeth) requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (119 in each group). The aim is to assess the effectiveness and utility of the ancillary drug substance, prednisolone acetate (1%) contained in CORTISOMOL SP (Zinc Oxide/Eugenol-type sealer) to help to decrease the possible postoperative painful reactions after root canal treatment. SEALITE REGULAR, which has a similar formulation except it is prednisolone acetate-free, is used as the comparator sealer. Procedures of root canal treatment will be conventional and standardized for all investigational centers. The canals will be cleaned, shaped and then obturated using a Zinc oxide/Eugenol-type sealer (CORTISOMOL SP or SEALITE REGULAR) and gutta-percha. Patients assess their pain for 7 days after permanent root canal obturation.

NCT ID: NCT04885686 Completed - Clinical trials for Root Canal Obturation

Endodontic Post-operative Pain Evaluation of Patients After Using Endomethasone N or Endomethasone SP (EndoPOP)

EndoPOP
Start date: June 22, 2021
Phase: N/A
Study type: Interventional

The study is a post-marketing performance and safety study, designed as a comparative, prospective, multicenter, simple-blind, randomized clinical trial. 300 subjects requiring a primary or a secondary root canal treatment will be enrolled in 2 groups (150 in each group). The aim of the study is to demonstrate the superiority of the hydrocortisone-containing root canal sealer Endomethasone N RCS, compared to the hydrocortisone-free root canal sealer Endomethasone SP RCS, with regard to reduction of the maximum post-operative spontaneous pain during the 7 days following the root canal treatment. Root canal treatment procedures will be in accordance with the allocation by randomisation of Endomethasone N RCS or Endomethasone SP RCS. The spontaneous and the Masticatory pain will be record at predefined times, a phone call will be done at 48h and a visit will be realized at day 7 (max Day 14).

NCT ID: NCT04753138 Completed - Postoperative Pain Clinical Trials

Outcome of SBO With Calcium Silicate Sealer vs WVC With Resin Based Sealer

Start date: February 24, 2021
Phase: N/A
Study type: Interventional

A single blinded randomized controlled trial. 212 subjects (teeth), 106 in each of the 2 groups will be recruited from the patients referred to Kuwait Board of Endodontics for primary root canal treatment. The aim is to compare the outcome of sealer-based obturation (SBO) with calcium silicate sealer versus warm vertical compaction (WVC) and resin based sealer. Preoperative PA radiograph and CBCT will be taken. A 1 year follow up period will be arranged and another PA radiograph and CBCT will be taken. The preoperative, postoperative and review clinical and radiographic data will be analyzed

NCT ID: NCT03874949 Completed - Clinical trials for Root Canal Obturation

Pain After Root Canal Obturation With Sealer Containing or Not 1% Enoxolone

Start date: April 2, 2019
Phase: N/A
Study type: Interventional

This study aims to assess the efficacy of a zinc oxide eugenol sealer containing Enoxolone, a non-steroidal anti inflammatory drug (NSAID) on the pain relief after endodontic treatment. The study design is a multicenter, doubled blinded randomized controlled trial. The comparator is the equivalent zinc oxide eugenol sealer without NSAID (allocation ratio is 1:1). The conventional endodontic treatment, using gutta percha and sealer, is done. Patients assess their pain for 7 days after permanent root obturation.

NCT ID: NCT03732170 Completed - Clinical trials for Root Canal Obturation

Root Canal Treatment With TotalFill® Bioceramic Sealer and AH Plus® Sealer

Start date: August 13, 2018
Phase: N/A
Study type: Interventional

The study design is a double blinded randomized controlled trial and 170 subjects (teeth) , 85 in each of the 2 groups, will be enrolled from the patients at the NUH dental centre endodontic unit. The study aims to assess how the use of TotalFill® bioceramic sealer affects the healing outcome of apical periodontitis compared to a control AH plus®. Conventional root canal treatment will be done during this study. Radiographs will be taken at each study visit during the study for root canal. The preoperative, postoperative and review clinical and radiographic data will be analysed.

NCT ID: NCT01728532 Completed - Clinical trials for Root Canal Obturation

Open, Multicentric Trial Evaluating the Efficacy and the Clinical Tolerance of PA0903 as Root Canal Sealer

PA0903
Start date: June 2012
Phase: N/A
Study type: Interventional

TRIAL TITLE: Open, randomized multicentric trial evaluating the efficacy and the clinical tolerance of PA0903 as root canal sealer SPONSOR: SEPTODONT, 58 rue du Pont de Créteil, 94107 Saint Maur des Fossés cedex Tel : + 33 1-49-76-74-26, Fax. : + 33 1- 49-76-71-91 Reference protocol: 11/001 PRODUCT NAME: PA0903 MEDICAL DEVICE: Class III: Root canal sealer Dose: not applicable Application : one single time DEVELOPMENTAL PHASE: not applicable (medical device class III)